novavax market cap november 2020

On November 30, 2020, Novavax (NVAX) had a market capitalization of $9.2B, based on 65.73M shares at a price of $139.50.

DATECLOSEVOLUMEOUTSTANDINGMARKET CAP
November 30 2020
$139.50
16,386,900
65,725,000
$9,168,637,500.00
November 27 2020
$125.69
11,777,400
65,725,000
$8,260,975,250.00
November 25 2020
$102.60
3,794,700
65,725,000
$6,743,385,000.00
November 24 2020
$95.33
3,099,200
65,725,000
$6,265,564,250.00
November 23 2020
$93.98
6,548,300
65,725,000
$6,176,835,500.00
November 20 2020
$86.55
2,557,300
65,725,000
$5,688,498,750.00
November 19 2020
$86.40
3,249,900
65,725,000
$5,678,640,000.00
November 18 2020
$89.91
2,525,200
65,725,000
$5,909,334,750.00
November 17 2020
$92.89
2,920,100
65,725,000
$6,105,195,250.00
November 16 2020
$90.65
6,852,900
65,725,000
$5,957,971,250.00
November 13 2020
$96.60
3,731,700
65,725,000
$6,349,035,000.00
November 12 2020
$90.87
4,953,400
65,725,000
$5,972,430,750.00
November 11 2020
$85.01
3,986,000
65,725,000
$5,587,282,250.00
November 10 2020
$78.74
6,854,400
65,725,000
$5,175,186,500.00
November 09 2020
$90.31
6,586,500
65,725,000
$5,935,624,750.00
November 06 2020
$89.86
1,893,100
65,725,000
$5,906,048,500.00
November 05 2020
$93.11
2,233,100
65,725,000
$6,119,654,750.00
November 04 2020
$87.27
2,272,300
65,725,000
$5,735,820,750.00
November 03 2020
$83.64
1,818,000
65,725,000
$5,497,239,000.00
November 02 2020
$82.40
1,855,200
65,725,000
$5,415,740,000.00